eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | systemic scleroderma |
| Comorbidity | C0011644|scleroderma |
| Sentences | 11 |
| PubMedID- 24650305 | Myopathy is a poor prognostic feature in systemic sclerosis: results from the canadian scleroderma research group (csrg) cohort. |
| PubMedID- 20740608 | Associations with digital ulcers in a large cohort of systemic sclerosis: results from the canadian scleroderma research group registry. |
| PubMedID- 19834761 | This paper describes systemic sclerosis sine scleroderma in a 17-year-old girl diagnosed initially as seronegative juvenile rheumatoid arthritis. |
| PubMedID- 20971496 | The objective of the study was to investigate the role of endothelin-1 in the pathogenesis of scleroderma renal crisis in patients with systemic sclerosis. |
| PubMedID- 21476377 | Normotensive scleroderma renal crisis in a patient with progressive systemic sclerosis: case report and review of literature. |
| PubMedID- 21781293 | Although we should not classify all ana-positive acute renal failure or ild as systemic sclerosis sine scleroderma, identifying ssc-specific autoantibodies may prove useful in understanding the pathogenetic mechanism and selecting treatment options. |
| PubMedID- 22556030 | Association of c-reactive protein with high disease activity in systemic sclerosis: results from the canadian scleroderma research group. |
| PubMedID- 20551097 | Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the eular scleroderma trial and research group (eustar) database. |
| PubMedID- 22247347 | Agreement with guidelines from a large database for management of systemic sclerosis: results from the canadian scleroderma research group. |
| PubMedID- 23661427 | Objective: systemic sclerosis sine scleroderma (ssssc) is an infrequent ssc variant characterized by visceral and immunological manifestations of ssc in the absence of clinically detectable skin involvement. |
| PubMedID- 20936135 | To describe the methodology of a study designed to determine whether systemic sclerosis (ssc) patients with incident scleroderma renal crisis (src) on angiotensin converting enzyme (ace) inhibitors prior to the onset of src have worse outcomes. |
Page: 1